Tang L - Search Results

1

Expert consensus on personalized initiation of glucose-lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease.

Zhang F, Ji L, Hong T, Guo L, Li Y, Zhu Z, Liu X, Liu F, Tang L, Zhang Y, Li J, Lü Q, Tong N. Zhang F, et al. Among authors: tang l. J Evid Based Med. 2022 Jun;15(2):168-179. doi: 10.1111/jebm.12474. Epub 2022 Jun 18. J Evid Based Med. 2022. PMID: 35715995

2

Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review.

Xu S, Zhang X, Tang L, Zhang F, Tong N. Xu S, et al. Among authors: tang l. Postgrad Med. 2017 Mar;129(2):205-215. doi: 10.1080/00325481.2017.1255537. Epub 2016 Nov 17. Postgrad Med. 2017. PMID: 27813442 Review.

3

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials.

Zhang F, Tang L, Zhang Y, Lü Q, Tong N. Zhang F, et al. Among authors: tang l. Sci Rep. 2017 Nov 22;7(1):15997. doi: 10.1038/s41598-017-16018-9. Sci Rep. 2017. PMID: 29167470 Free PMC article.

4

Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials.

Li J, Tong Y, Zhang Y, Tang L, Lv Q, Zhang F, Hu R, Tong N. Li J, et al. Among authors: tang l. Clin Ther. 2016 Feb;38(2):372-386.e6. doi: 10.1016/j.clinthera.2015.12.006. Epub 2016 Jan 7. Clin Ther. 2016. PMID: 26774276 Review.

5

Weight loss effect of glucagon-like peptide-1 mimetics on obese/overweight adults without diabetes: A systematic review and meta-analysis of randomized controlled trials.

Zhang F, Tong Y, Su N, Li Y, Tang L, Huang L, Tong N. Zhang F, et al. Among authors: tang l. J Diabetes. 2015 May;7(3):329-39. doi: 10.1111/1753-0407.12198. Epub 2014 Sep 10. J Diabetes. 2015. PMID: 25043423 Review.

6

The association of visceral adipose tissue and subcutaneous adipose tissue with metabolic risk factors in a large population of Chinese adults.

Tang L, Zhang F, Tong N. Tang L, et al. Clin Endocrinol (Oxf). 2016 Jul;85(1):46-53. doi: 10.1111/cen.13013. Epub 2016 Feb 12. Clin Endocrinol (Oxf). 2016. PMID: 26725580

7

Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.

Zhang F, Wan Q, Cao H, Tang L, Li D, Lü Q, Yan Z, Li J, Yang Q, Zhang Y, Tong N. Zhang F, et al. Among authors: tang l. BMJ Open. 2018 May 9;8(5):e019735. doi: 10.1136/bmjopen-2017-019735. BMJ Open. 2018. PMID: 29743321 Free PMC article.

8

Evaluation of the HbA1c Reduction Cut Point for a Nonglycemic Effect on Cardiovascular Benefit of Hypoglycemic Agents in Patients with Type 2 Diabetes Based on Endpoint Events.

Wu Y, Tang L, Zhang F, Yan Z, Li J, Tong N. Wu Y, et al. Among authors: tang l. Int J Endocrinol. 2018 Apr 19;2018:8457538. doi: 10.1155/2018/8457538. eCollection 2018. Int J Endocrinol. 2018. PMID: 29849624 Free PMC article. Review.

9

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Zhang F, Xu S, Tang L, Pan X, Tong N. Zhang F, et al. Among authors: tang l. Front Endocrinol (Lausanne). 2020 Jun 5;11:288. doi: 10.3389/fendo.2020.00288. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32582019 Free PMC article.

10

Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial.

Zhang F, Tang L, Li J, Yan Z, Li J, Tong N. Zhang F, et al. Among authors: tang l. Diabetes Metab Syndr Obes. 2021 Mar 18;14:1243-1252. doi: 10.2147/DMSO.S293307. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33776461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,768 results

Search Page